Key researcher moves back to drug development

07/30/2006 | Washington Post, The

CoGenesys, launched by Human Genome Sciences co-founder Craig Rosen and his partner Steven Mayer, aims to develop new drugs that will interest big firms rather than create products to take to market. Rosen's move to the company is an example of the maturing of the biotech industry and of scientific entrepreneurs leaving product commercialization to return to the laboratories.

View Full Article in:

Washington Post, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Confidential
Pompano Beach, FL